Overview

Umbilical Cord Blood Transplantation From Unrelated Donors

Status:
Recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This study is a single-center, treatment protocol with 4 possible preparative regimens, designed to validate the process of umbilical cord blood stem cell transplantation at our institution.
Phase:
Phase 1
Details
Lead Sponsor:
University of Rochester
Treatments:
Busulfan
Cyclophosphamide
Fludarabine
Fludarabine phosphate
Melphalan
Mesna